...
首页> 外文期刊>The journal of clinical psychiatry >The neurobiology of the switch process in bipolar disorder: a review.
【24h】

The neurobiology of the switch process in bipolar disorder: a review.

机译:双相情感障碍转换过程的神经生物学:综述。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The singular phenomenon of switching from depression to its opposite state of mania or hypomania, and vice versa, distinguishes bipolar disorder from all other psychiatric disorders. Despite the fact that it is a core aspect of the clinical presentation of bipolar disorder, the neurobiology of the switch process is still poorly understood. In this review, we summarize the clinical evidence regarding somatic interventions associated with switching, with a particular focus on the biologic underpinnings presumably involved in the switch process. DATA SOURCES: Literature for this review was obtained through a search of the MEDLINE database (1966-2008) using the following keywords and phrases: switch, bipolar disorder, bipolar depression, antidepressant, SSRIs, tricyclic antidepressants, norepinephrine, serotonin, treatment emergent affective switch, mania, hypomania, HPA-axis, glucocorticoids, amphetamine, dopamine, and sleep deprivation. STUDY SELECTION: All English-language, peer-reviewed, published literature, including randomized controlled studies, naturalistic and open-label studies, and case reports, were eligible for inclusion. DATA SYNTHESIS: Converging evidence suggests that certain pharmacologic and nonpharmacologic interventions with very different mechanisms of action, such as sleep deprivation, exogenous corticosteroids, and dopaminergic agonists, can trigger mood episode switches in patients with bipolar disorder. The switch-inducing potential of antidepressants is unclear, although tricyclic antidepressants, which confer higher risk of switching than other classes of antidepressants, are a possible exception. Several neurobiological factors appear to be associated with both spontaneous and treatment-emergent mood episode switches; these include abnormalities in catecholamine levels, up-regulation of neurotrophic and neuroplastic factors, hypothalamic-pituitary-adrenal axis hyperactivity, and circadian rhythms. CONCLUSIONS: There is a clear need to improve our understanding of the neurobiology of the switch process; research in this field would benefit from the systematic and integrated assessment of variables associated with switching.
机译:目的:从抑郁症转变为躁狂或轻躁狂相反状态的奇异现象,反之亦然,将双相情感障碍与所有其他精神疾病区分开来。尽管这是双相情感障碍临床表现的一个核心方面,但对转换过程的神经生物学仍然知之甚少。在这篇综述中,我们总结了与转换相关的体细胞干预的临床证据,特别关注了可能与转换过程有关的生物学基础。数据来源:这篇综述的文献是通过使用以下关键词和短语通过搜索MEDLINE数据库(1966-2008)获得的:开关,双相情感障碍,双相抑郁,抗抑郁药,SSRI,三环类抗抑郁药,去甲肾上腺素,5-羟色胺,治疗紧急情感开关,躁狂,轻躁狂,HPA轴,糖皮质激素,苯丙胺,多巴胺和睡眠不足。研究选择:所有英语,经同行评审,已发表的文献,包括随机对照研究,自然主义和开放标签研究以及病例报告,均符合纳入条件。数据综合:越来越多的证据表明,某些具有不同作用机制的药理和非药理干预措施,例如睡眠剥夺,外源性皮质类固醇和多巴胺能激动剂,可以触发双相情感障碍患者的情绪发作转换。尽管三环类抗抑郁药可能比其他类别的抗抑郁药具有更高的转换风险,但尚不清楚抗抑郁药的诱导转换的潜力。几种神经生物学因素似乎与自发的和治疗出现的情绪发作转换有关。这些包括儿茶酚胺水平异常,神经营养和神经增生因子的上调,下丘脑-垂体-肾上腺轴亢进和昼夜节律。结论:显然有必要增进我们对转换过程的神经生物学的理解;该领域的研究将受益于与转换相关的变量的系统和综合评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号